All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73583550" target="_blank" >RIV/61989592:15110/17:73583550 - isvavai.cz</a>

  • Alternative codes found

    RIV/00098892:_____/17:N0000034

  • Result on the web

    <a href="http://dx.doi.org/10.5507/bp.2017.015" target="_blank" >http://dx.doi.org/10.5507/bp.2017.015</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5507/bp.2017.015" target="_blank" >10.5507/bp.2017.015</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage

  • Original language description

    Aims. To evaluate the serum levels of matrix metalloproteinase-3 (MMP-3) as a potential marker of disease aktivity and joint damage in 92 patients with rheumatoid arthritis (RA), compared to 24 osteoarthritis (OA) patients and 26 healthy controls. Methods. The concentrations of MMP-3 were measured by ELISA using the commercial kit AESKULISA DF MMP-3 (AESKU.Diagnostics, Germany) and compared with other laboratory parameters routinely used to assess the dinase status, clinical score (DAS28) and radiographic stage in the group of RA patients. Results. The mean serum concentrations of MMP-3 were 199.1 ± 160 ng/mL in RA patients, 113.9 ± 96.9 ng/mL in OA patients and 48.3 ± 19.2 in healthy controls. The differences were highly significant: RA patients and healthy controls (P&lt;0.0001), RA and OA patients (P=0.008) as well as between OA patients and controls (P=0.009). MMP-3 concentrations were further compared with other laboratory parameters and clinical and structural damage data. There were correlations between MMP-3 and CRP (r=0.304, P&lt;0.01), DAS28 (r=0.301, P&lt;0.05), levels of anti-cyclic citrullinated peptide antibodies (r=0.241, P&lt;0.05), erythrocyte sedimentation rate (r=0.200, P=0.059) and radiographic disease stage (r=0.197, P=0.063). Conclusion. These results demonstrated that measurement of MMP-3 could become a marker of disease activity in RA patients.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30226 - Rheumatology

Result continuities

  • Project

    <a href="/en/project/NV15-28659A" target="_blank" >NV15-28659A: Prognostic factors of organ and tissue damage in selected systemic autoimunne diseases</a><br>

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedical Papers-Olomouc

  • ISSN

    1213-8118

  • e-ISSN

  • Volume of the periodical

    161

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    7

  • Pages from-to

    296-302

  • UT code for WoS article

    000418004800009

  • EID of the result in the Scopus database